These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 25823216)

  • 1. Vascular aneurysms: a perspective.
    Chakraborti S; Chowdhury A; Alam MN; Sarkar J; Mandal A; Pramanik A; Chakraborti T
    Indian J Biochem Biophys; 2014 Dec; 51(6):449-56. PubMed ID: 25823216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of plasminogen activation, matrix metalloproteinases and urokinase-type plasminogen activator-mediated extracellular matrix degradation in human osteosarcoma cell line MG63 by interleukin-1 alpha.
    de Bart AC; Quax PH; Löwik CW; Verheijen JH
    J Bone Miner Res; 1995 Sep; 10(9):1374-84. PubMed ID: 7502710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urokinase-generated plasmin activates matrix metalloproteinases during aneurysm formation.
    Carmeliet P; Moons L; Lijnen R; Baes M; Lemaître V; Tipping P; Drew A; Eeckhout Y; Shapiro S; Lupu F; Collen D
    Nat Genet; 1997 Dec; 17(4):439-44. PubMed ID: 9398846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extracellular proteolysis in the development and progression of atherosclerosis.
    Lijnen HR
    Biochem Soc Trans; 2002 Apr; 30(2):163-7. PubMed ID: 12023844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiotensin II induces the production of MMP-3 and MMP-13 through the MAPK signaling pathways via the AT(1) receptor in osteoblasts.
    Nakai K; Kawato T; Morita T; Iinuma T; Kamio N; Zhao N; Maeno M
    Biochimie; 2013 Apr; 95(4):922-33. PubMed ID: 23277113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inactivation of PI3Kδ induces vascular injury and promotes aneurysm development by upregulating the AP-1/MMP-12 pathway in macrophages.
    Zheng L; Xing L; Zeng C; Wu T; Gui Y; Li W; Lan T; Yang Y; Gu Q; Qi C; Zhang Q; Tang F; He X; Wang L
    Arterioscler Thromb Vasc Biol; 2015 Feb; 35(2):368-77. PubMed ID: 25503990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of the mural thrombus as a site of protease release and activation in human aortic aneurysms.
    Fontaine V; Jacob MP; Houard X; Rossignol P; Plissonnier D; Angles-Cano E; Michel JB
    Am J Pathol; 2002 Nov; 161(5):1701-10. PubMed ID: 12414517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mesenchymal stem cells attenuate angiotensin II-induced aortic aneurysm growth in apolipoprotein E-deficient mice.
    Hashizume R; Yamawaki-Ogata A; Ueda Y; Wagner WR; Narita Y
    J Vasc Surg; 2011 Dec; 54(6):1743-52. PubMed ID: 21908146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of experimental abdominal aortic aneurysms in mice by treatment with pyrrolidine dithiocarbamate, an antioxidant inhibitor of nuclear factor-kappaB.
    Parodi FE; Mao D; Ennis TL; Bartoli MA; Thompson RW
    J Vasc Surg; 2005 Mar; 41(3):479-89. PubMed ID: 15838484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasmin and matrix metalloproteinases in vascular remodeling.
    Lijnen HR
    Thromb Haemost; 2001 Jul; 86(1):324-33. PubMed ID: 11487021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Down-regulation of urokinase plasminogen activator and matrix metalloproteinases and up-regulation of their inhibitors by a novel nutrient mixture in human prostate cancer cell lines PC-3 and DU-145.
    Roomi MW; Kalinovsky T; Rath M; Niedzwiecki A
    Oncol Rep; 2011 Dec; 26(6):1407-13. PubMed ID: 21874261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The evolving plasticity of coagulation protease-dependent cytoprotective signalling.
    Shahzad K; Isermann B
    Hamostaseologie; 2011 Aug; 31(3):179-84. PubMed ID: 21691672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Roles of serine proteases and matrix metalloproteinases in tumor invasion and angiogenesis].
    Masson V
    Bull Mem Acad R Med Belg; 2006; 161(5):320-6. PubMed ID: 17283905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Matrix metalloproteinase-specific inhibition of Ca2+ entry mechanisms of vascular contraction.
    Chew DK; Conte MS; Khalil RA
    J Vasc Surg; 2004 Nov; 40(5):1001-10. PubMed ID: 15557917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunosuppressive drug azathioprine reduces aneurysm progression through inhibition of Rac1 and c-Jun-terminal-N-kinase in endothelial cells.
    Marinkovic G; Hibender S; Hoogenboezem M; van Broekhoven A; Girigorie AF; Bleeker N; Hamers AA; Stap J; van Buul JD; de Vries CJ; de Waard V
    Arterioscler Thromb Vasc Biol; 2013 Oct; 33(10):2380-8. PubMed ID: 23950142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemistry of matrix metalloproteinases and their inhibitors in thoracic aortic aneurysms and aortic valves of patients with Marfan's syndrome.
    Segura AM; Luna RE; Horiba K; Stetler-Stevenson WG; McAllister HA; Willerson JT; Ferrans VJ
    Circulation; 1998 Nov; 98(19 Suppl):II331-7; discussion II337-8. PubMed ID: 9852923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of IL-1alpha on the expression of matrix metalloproteinases, plasminogen activators, and their inhibitors in osteoblastic ROS 17/2.8 cells.
    Fujisaki K; Tanabe N; Suzuki N; Mitsui N; Oka H; Ito K; Maeno M
    Life Sci; 2006 Mar; 78(17):1975-82. PubMed ID: 16313928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated expression of membrane-type 1 and 3 matrix metalloproteinases in rat vascular smooth muscle cells activated by arterial injury.
    Shofuda K; Nagashima Y; Kawahara K; Yasumitsu H; Miki K; Miyazaki K
    Lab Invest; 1998 Aug; 78(8):915-23. PubMed ID: 9714179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Upregulation of urokinase-type plasminogen activator and inhibitor and gelatinase expression via 3 mitogen-activated protein kinases and PI3K pathways during the early development of osteoarthritis.
    Hsieh YS; Yang SF; Lue KH; Chu SC; Li TJ; Lu KH
    J Rheumatol; 2007 Apr; 34(4):785-93. PubMed ID: 17299841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytokine pattern determines the progression of experimental periodontal disease induced by Actinobacillus actinomycetemcomitans through the modulation of MMPs, RANKL, and their physiological inhibitors.
    Garlet GP; Cardoso CR; Silva TA; Ferreira BR; Avila-Campos MJ; Cunha FQ; Silva JS
    Oral Microbiol Immunol; 2006 Feb; 21(1):12-20. PubMed ID: 16390336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.